User menu

A risk-benefit assessment of alendronate in the treatment of involutional osteoporosis.

Bibliographic reference Devogelaer, Jean-Pierre. A risk-benefit assessment of alendronate in the treatment of involutional osteoporosis.. In: Drug safety : an international journal of medical toxicology and drug experience, Vol. 19, no. 2, p. 141-54 (1998)
Permanent URL http://hdl.handle.net/2078.1/29576